Approval · Notice of Compliance 29487 · 2022
TEMAZEPAM: Notice of Compliance 29487
Issued November 17, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29487
- Date
- November 17, 2022
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to The Product Monograph. Migrate the Product Monograph to the 2020 Format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEMAZEPAM | Not yet assigned | — |